• Home
  • GACD Mental Health Implementation Measures

MH01: Supervised Treatment in Out-Patients for Schizophrenia (STOPS+)
MH02: Cognitive Stimulation Therapy for dementia: International implementation in Brazil, India & Tanzania (CST-International)
MH03: Optimising implementation strategies of the scale-up of a primary care psychological intervention: The Friendship Bench
MH04: Youth Wellbeing in China and Central America: Implementation of an Integrated Prevention and Intervention Program
MH05: Implementation research: community intervention to prevent repeated suicide attempts in Ningxia China and Nunavut Canada
MH06: Enhanced Measurement-Based care Effectiveness for Depression (EMBED): A Canada-China implementation project
MH07: Linking Hearts: Advancing Mental Health Care of University Students Through Interdisciplinary Collaboration (in Jinan)
MH08: Shared Care for ADHD in Children and Youth: Merging the Canadian and Chinese Experiences
MH09: Screening and management of perinatal depression within primary care
MH10: Standardizing the treatment, prevention, and management of depression in China: a multi-disciplinary approach
MH11: Mental health promotion at workplace in low- and middle-income countries in Asia
MH12: A Study on Rights-based Self-learning Tools to Promote Mental Health, Well-being & Resilience after Disasters
MH13: Exploring Stigma, Discrimination & Recovery-Based Perspectives toward Mental Illness & Substance Use Problems in Brazil
MH14: Indigenous communities, local culture and mental health in Mexican adolescent population. Community Intervention analysis.
MH15: A culturally appropriate approach to improve mental health outcomes in Sri Lanka and China: Mental Health First Aid
MH16: Systematic Medical Appraisal, Referral and Treatment for Common Mental Disorders in India – SMART Mental Health
MH17: Indigenous Mental Health Model of Care: RCT based on a trans-diagnostic CBT program co-designed with Community
MH18: A randomised stepped wedge trial of the scaling up of a community-based alcohol education program in rural Sri Lanka
MH19: Primary care e-screening for mental health among TeTai Tokerau youth
MH20: Pathways to First Episode Psychosis and Outcomes In Maori
MH21: Indigenous Solutions: Enabling Māori & Pacific mental health resilience
MH22: Implementation of an effective and cost-effective intervention for patients with psychotic disorders in low- and middle-income countries in South Eastern Europe (IMPULSE)
MH23: Using Peer Support In Developing Empowering Mental Health Services (UPSIDES)
MH24: Prevention of child mental health problems in Southeastern Europe – Adapt, Optimize, Test, and Extend Parenting for Lifelong Health (RISE)
MH25: Large-scale implementation of community based mental health care for people with severe and Enduring mental ill health in Europe (RECOVER-E)
MH26: Refugee Emergency: Defining and Implementing Novel Evidence-based psychosocial interventions (RE-DEFINE)
MH27: Scale-up of Prevention and Management of Alcohol Use Disorders and Comorbid Depression in Latin America (SCALA)
MH28: Prevention of Dementia using Mobile phone Applications (PRODEMOS)
MH29: How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model (RECAGE)
MH30: Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine
MH31: Depression And Primary-care Partnership for Effectiveness-implementation Research (DAPPER)
MH32: Evaluating Implementation Strategies to Scale-up Transdiagnostic Evidence-based Mental Health Care in Zambia
MH33: IMPlementation of evidence based facility and community interventions to reduce the treatment gap for depRESSion (IMPRESS)
MH34: OnTrackChile for First Episode Psychosis

  • Secretariat of Government of Health, Argentina

    Dr Raúl Mejia is the Director of Health Research at the Ministry of Health

  • National Health and Medical Research Council, Australia

    NHMRC http://www.nhmrc.gov.au/ Australia

    The National Health and Medical Research Council is a founding member. The Chief Executive, Prof Anne Kelso is currently the Chair of the GACD Strategy Board.

  • São Paulo Research Foundation, Brazil

    FAPESP http://www.fapesp.br/en/ Brazil

    São Paulo Research Foundation – FAPESP, joined the GACD in 2016. It’s Scientific Director, Prof Brito is the GACD Strategy Board member.

  • Canadian Institutes of Health Research

    The Canadian Institute of Health Research is a founding member of the GACD and its President, Dr Michael Strong is a GACD Strategy Board member.

  • Chinese Academy of Medical Sciences

    The Chinese Academy of Medical Sciences (CAMS) is a founding member, and its President Dr Chen Wang is a GACD Strategy Board Member.

  • Directorate General - Research & Innovation, European Commission

    The Health Directorate of the Research & Innovation Directorate General at the European Commission is a GACD associate member. Dr Barbara Kerstiëns is the Head of Unit responsible for non-communicable diseases and the challenge of healthy ageing and sits on the GACD Strategy Board.

  • Indian Council of Medical Research

    The Indian Council of Medical Research joined GACD as its second low- and middle-income country associate member. Professor Balram Bhargava, Director General of the Indian Council of Medical Research (ICMR) is a GACD Strategy Board Member.

  • Agency for Medical Research and Development, Japan

    Japan joined GACD as an associate member in 2016. The President of AMED, Dr Makoto Suematsu is the GACD Strategy Board member.

  • Health Research Council, New Zealand

    HRC http://www.hrc.govt.nz/ New Zealand

    New Zealand’s Health Research Council joined GACD in 2017, and Prof Kathryn McPherson, Executive Director of New Zealand’s HRC sits on the GACD Strategy Board.

  • South African Medical Research Council

    SAMRC http://www.mrc.ac.za/home.htm South Africa

    The South African Medical Research council brings important representation from the African continent to the GACD. Prof Glenda Gray, President of the South African MRC, is a GACD Strategy Board member.

  • Health Systems Research Institute, Thailand

    Dr Nopporn Cheanklin, Director of Thailand’s Health Systems Research Institute sits on the GACD Strategy Board.

  • UK Medical Research Council

    MRC http://www.mrc.ac.uk/index.htm United Kingdom

    The UK Medical Research Council is a founding member. Dr Mark Palmer, Head of International Strategy is a GACD Strategy Board member.

  • US National Institutes of Health

    NIH http://www.nih.gov/ United States

    The NIH is a founding member of GACD. We work specifically with the National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Mental Health (NIHM) and the Fogarty International Center (FIC). Dr Roger Glass, Director of the Fogarty International Center, is a GACD Strategy Board member.

  • National Council of Scientific and Technological Development, Brazil

    CNPq http://www.cnpq.br/ Brazil

    Prof Joao Luiz Filgueiras de Azevedo, President of the National Council of Scientific and Technological Development (CNPq) is a member of the GACD Strategy Board.

Share this page